Cite
604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer.
MLA
Leyvraz, S., et al. “604TiP ON-TRK: A Non-Interventional Study of Larotrectinib in Patients with TRK Fusion Cancer.” Annals of Oncology, vol. 31, Sept. 2020, p. S503. EBSCOhost, https://doi.org/10.1016/j.annonc.2020.08.718.
APA
Leyvraz, S., Yang, J. .-H., Casali, P. G., Castro, G., Kim, E. S., Lassen, U. N., Lopez-Rios, F., Penault-Llorca, F., Pappo, A., Rudzinski, E. R., Tabatabai, G., Vassal, G., Reeves, J. A., Nogai, H., Fellous, M., Drilon, A., Brose, M. S., & Trent, J. (2020). 604TiP ON-TRK: A non-interventional study of larotrectinib in patients with TRK fusion cancer. Annals of Oncology, 31, S503. https://doi.org/10.1016/j.annonc.2020.08.718
Chicago
Leyvraz, S., J.C-H. Yang, P.G. Casali, G. Castro, E.S. Kim, U.N. Lassen, F. Lopez-Rios, et al. 2020. “604TiP ON-TRK: A Non-Interventional Study of Larotrectinib in Patients with TRK Fusion Cancer.” Annals of Oncology 31 (September): S503. doi:10.1016/j.annonc.2020.08.718.